Randomized trial · people

HGH: weekly somatrogon 9.65 vs daily 7.87 cm/year in GHD children

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In children with GHD, a weekly long-acting growth hormone matched daily somatropin on growth over a year, though its injections were reported as more painful.

Kind
Randomized trial
Studied in
People
Number studied
44
Published
2022
Journal
Horm Res Paediatr

What they tested

The team tested whether once-weekly somatrogon, a long-acting growth hormone, works as well and as safely as once-daily somatropin (Genotropin) in Japanese children with growth hormone deficiency (GHD).

How the study was done

A randomized, open-label phase 3 trial in 44 Japanese children with GHD who had not yet entered puberty. Children got either weekly somatrogon (stepped up over 6 weeks to 0.66 mg/kg/week) or daily Genotropin (the 0.025 mg/kg/day arm) for 12 months.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking HGH? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

The main measure was height velocity, meaning how fast the children grew over a year. Children on weekly somatrogon grew 9.65 cm/year, compared with 7.87 cm/year on daily Genotropin, a difference of +1.79 cm/year (95% confidence interval 0.97-2.61). Because this cleared the preset margin of -1.8 cm/year, the team judged the weekly shot comparable to the daily one. Most side effects in both groups were mild to moderate, a similar share in each group had injection-site pain, and the somatrogon group rated its injections as more painful.

What it doesn’t show

The trial was open-label, so families and doctors knew which treatment each child got. It was small, lasted 12 months, and included only prepubertal Japanese children with GHD.

The paper

Horikawa et al. Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study. Horm Res Paediatr. 2022.

The compound

More studies on HGH

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking HGH? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo